Literature DB >> 8445927

Changes in alveolar oxygen and carbon dioxide concentration and oxygen consumption during lung preservation. The maintenance of aerobic metabolism during lung preservation.

H Date1, A Matsumura, J K Manchester, J M Cooper, O H Lowry, J D Cooper.   

Abstract

The lung is the only organ to which oxygen may be supplied after its blood supply is stopped. Before this study, we were not certain whether lung cells were able to maintain aerobic metabolism with the oxygen in the alveoli during preservation. Excised rabbit lungs were used to measure changes in the concentration of oxygen and carbon dioxide in the airway and changes in glucose, glucose-6-phosphate, lactate, adenosine triphosphate, and phosphocreatine levels in the lung tissue during preservation under different conditions. Twenty-seven lungs were flushed with low-potassium dextran electrolyte solution, inflated with room air, and preserved at 1 degree C (n = 8), 10 degrees C (n = 8), or 22 degrees (n = 11) for 4, 12, or 24 hours. Eight additional lungs were inflated with 100% nitrogen and preserved at 10 degrees C for 4 (n = 4) or 24 (n = 4) hours. Oxygen levels decreased and carbon dioxide levels increased in the airway of the lungs that were inflated with room air at rates dependent on the preservation temperature. The increase of carbon dioxide in the lungs that were inflated with 100% nitrogen was very small. When the oxygen was not available in the alveoli, lactate accumulated, and adenosine triphosphate and phosphocreatine decreased in the lung tissue. We concluded that lung cells are able to maintain aerobic metabolism with the oxygen in the alveoli during preservation and that the maintenance of aerobic metabolism may be essential to maintain the optimum viability of preserved lung tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445927

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

Review 1.  Preservation solution for lung transplantation.

Authors:  Yoshinori Okada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-12

2.  Effects of glucose on rat lung preservation: report of a study conducted on an isolated lung reperfusion model utilizing. Another isolated lung as a "deoxygenator".

Authors:  T Hanagiri; H Igisu; T Shiraishi; M Ikeda; K Yasumoto
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 3.  Overview of clinical lung transplantation.

Authors:  Jonathan C Yeung; Shaf Keshavjee
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

4.  Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation.

Authors:  S Fischer; S D Cassivi; A M Xavier; J A Cardella; E Cutz; V Edwards; M Liu; S Keshavjee
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

Review 5.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

6.  The effects of recombinant tissue-type plasminogen activator (rt-PA) on canine cadaver lung transplantation.

Authors:  S Akasaka; H Nishi; M Aoe; H Date; A Andou; N Shimizu
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

7.  Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death.

Authors:  Gerhard Preissler; Florian Loehe; Ines V Huff; Ulrich Ebersberger; Vladimir V Shuvaev; Iris Bittmann; Iris Hermanns; James C Kirkpatrick; Karl Fischer; Martin E Eichhorn; Hauke Winter; Karl W Jauch; Steven M Albelda; Vladimir R Muzykantov; Rainer Wiewrodt
Journal:  Transplantation       Date:  2011-08-27       Impact factor: 4.939

8.  In vitro modeling of nonhypoxic cold ischemia-reperfusion simulating lung transplantation.

Authors:  Monica Casiraghi; Jason R Tatreau; John B Abano; John W Blackwell; Larry Watson; Keith Burridge; Scott H Randell; Thomas M Egan
Journal:  J Thorac Cardiovasc Surg       Date:  2009-09       Impact factor: 5.209

9.  Effects of inhaled nitric oxide in canine lung transplantation from non-heart-beating donor.

Authors:  S Takashima; H Date; M Aoe; M Yamashita; A Andou; N Shimizu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08

Review 10.  Pulmonary transplantation.

Authors:  R D Davis; M K Pasque
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.